Evaluation of colistin dose in chronic intermittent dialysis patients: a population pharmacokinetics approach

被引：0
|
作者：
Marsot, A. [1 ]
Lebrun, G. [2 ]
Boulamery, A. [1 ]
Jaubert, D. [2 ]
Brunet, P. [2 ]
Bruguerolle, B. [1 ]
Simon, N. [1 ]
机构：
[1] Hop Enfants La Timone, APHM, Serv Pharmacol Clin, Marseille, France
[2] Hop Conception, APHM, Ctr Nephrol & Transplantat Renale, Marseille, France
来源：
FUNDAMENTAL & CLINICAL PHARMACOLOGY | 2013年 / 27卷
关键词：
colistin; pharmacokinetics; modelling; dialysis patients;
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：72 / 72
页数：1
相关论文
共 50 条
  • [1] Population Pharmacokinetics of Colistin Methanesulfonate and Colistin in Critically Ill Patients with Acute Renal Failure Requiring Intermittent Hemodialysis
    Jacobs, M.
    Gregoire, N.
    Megarbane, B.
    Gobin, P.
    Balayn, D.
    Marchand, S.
    Mimoz, O.
    Couet, W.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2016, 60 (03) : 1788 - 1793
  • [2] VANCOMYCIN PHARMACOKINETICS IN PATIENTS UNDERGOING CHRONIC INTERMITTENT PERITONEAL-DIALYSIS
    GLEW, RH
    PAVUK, RA
    SHUSTER, A
    ALFRED, HJ
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 1982, 20 (12) : 559 - 563
  • [3] Population pharmacokinetics of colistin in critically ill patients: the loading dose rationale revisited
    Gregoire, N.
    Mimoz, O.
    Megarbane, B.
    Comets, E.
    Chatelier, D.
    Lasocki, S.
    Balayn, D.
    Gobin, P.
    Marchand, S.
    Couet, W.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2014, 28 : 19 - 19
  • [4] Colistin Population Pharmacokinetics after Application of a Loading Dose of 9 MU Colistin Methanesulfonate in Critically Ill Patients
    Karaiskos, Ilias
    Friberg, Lena E.
    Pontikis, Konstantinos
    Ioannidis, Konstantinos
    Tsagkari, Vasiliki
    Galani, Lamprini
    Kostakou, Eirini
    Baziaka, Fotini
    Paskalis, Charalambos
    Koutsoukou, Antonia
    Giamarellou, Helen
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2015, 59 (12) : 7240 - 7248
  • [5] Pharmacokinetics and dose recommendations of Niaspan® in chronic kidney disease and dialysis patients
    Reiche, Ines
    Westphal, Sabine
    Martens-Lobenhoffer, Jens
    Troeger, Uwe
    Luley, Claus
    Bode-Boeger, Stefanie M.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2011, 26 (01) : 276 - 282
  • [6] Pharmacokinetics of single-dose rosiglitazone in chronic ambulatory peritoneal dialysis patients
    Aramwit, P.
    Supasyndh, O.
    Sriboonruang, T.
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2008, 33 (06) : 685 - 690
  • [7] Pharmacokinetics of colistin in critically-ill patients on sustained low-efficiency dialysis: a population pharmacokinetic study
    Boonyasiri, Adhiratha
    Fuhs, Dominika
    Naorungroj, Thummaporn
    Wang, Lu
    Wang, Jiping
    Ratanarat, Ranistha
    Li, Jian
    Nation, Roger
    Thammalikikul, Visanu
    Landersdorfer, Cornelia
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2025, 152
  • [8] Population Pharmacokinetics of Colistin Methanesulfonate Sodium and Colistin in Critically Ill Patients: A Systematic Review
    Zabidi, Mohd Shafie
    Abu Bakar, Ruzilawati
    Musa, Nurfadhlina
    Mustafa, Suzana
    Wan Yusuf, Wan Nazirah
    PHARMACEUTICALS, 2021, 14 (09)
  • [9] TUBERCULOSIS IN PATIENTS UNDER CHRONIC INTERMITTENT DIALYSIS
    HELM, EB
    FREI, U
    FASSBINDER, W
    MUNCHENER MEDIZINISCHE WOCHENSCHRIFT, 1983, 125 (39): : 851 - 852
  • [10] Population pharmacokinetic study of colistin for dose optimization in patients with acute on chronic liver failure (ACLF) patients
    Bhandari, Ritika
    Shafiq, Nusrat
    Murali, Naveen
    Vij, Soumya
    Verma, Nipun
    Pandey, Avaneesh Kumar
    Gota, Vikram Prakash
    Rajan, M. Surulivel
    Duseja, Ajay Kumar
    Malhotra, Samir
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2025, 152
12345